Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Hoegenauer, C; Hammer, HF; Mahnert, A; Moissl-Eichinger, C.
Methanogenic archaea in the human gastrointestinal tract.
Nat Rev Gastroenterol Hepatol. 2022; 19(12):805-813
Doi: 10.1038/s41575-022-00673-z
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Hoegenauer Christoph
-
Moissl-Eichinger Christine
- Co-authors Med Uni Graz
-
Hammer Heinz
-
Mahnert Alexander
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- The human microbiome is strongly interwoven with human health and disease. Besides bacteria, viruses and eukaryotes, numerous archaea are located in the human gastrointestinal tract and are responsible for methane production, which can be measured in clinical methane breath analyses. Methane is an important readout for various diseases, including intestinal methanogen overgrowth. Notably, the archaea responsible for methane production are largely overlooked in human microbiome studies due to their non-bacterial biology and resulting detection issues. As such, their importance for health and disease remains largely unclear to date, in particular as not a single archaeal representative has been deemed to be pathogenic. In this Perspective, we discuss the current knowledge on the clinical relevance of methanogenic archaea. We explain the archaeal unique response to antibiotics and their negative and positive effects on human physiology, and present the current understanding of the use of methane as a diagnostic marker.
- Find related publications in this database (using NLM MeSH Indexing)
-
Humans - administration & dosage
-
Archaea - physiology
-
Euryarchaeota - administration & dosage
-
Gastrointestinal Tract - microbiology
-
Methane - administration & dosage
-
Bacteria - administration & dosage